China
By Christopher M. Matthews | May 3rd, 2011

In August 2010, SciClone Pharmaceuticals Inc. disclosed that the SEC and the Justice Department are investigating it for potential violations of the Foreign Corrupt Practices Act.

By Aruna Viswanatha | May 3rd, 2011

The executives had previously been placed on administrative leave.

By Christopher M. Matthews | April 29th, 2011

The DOJ’s Criminal Fraud Section and the SEC are investigating at least five other major pharmaceutical companies: GlaxoSmithKline PLC; Baxter International Inc.; Eli Lilly & Co.; Bristol-Myers Squibb Co.; and Merck & Co.

By Christopher M. Matthews | April 20th, 2011

The case has the trappings of an FCPA soap opera: previously undisclosed documents revealing internal DOJ disagreements over the case, squabbling between a major Washington firm and local counsel over legal fees, and the future of a man described by his attorney as a “whistleblower.”

By Aruna Viswanatha | April 19th, 2011

The Justice Department fired back again at defense lawyers’ attempts to limit the scope of a key foreign bribery law and said such attempts unjustifiably transform a fact-based question into a sweeping legal one.

By Aruna Viswanatha | April 15th, 2011

Prosecutors from the Southern District of New York have joined the investigation, as more than a dozen top law firms have been hired to represent executives at the company.

By Aruna Viswanatha | April 1st, 2011

The company paid $300,000 last year to settle foreign bribery charges from the Securities and Exchange Commission.

By David Stout | March 31st, 2011

Accusations from across the world illustrate the global reach of a gambling corporation.

By Aruna Viswanatha | March 18th, 2011

Some of the around $207,000 in bribes the company paid in South Korea were delivered in shopping bags stuffed with cash, the SEC said.

By David Stout | March 18th, 2011

A case that has already spawned many questions of law gives rise to yet another.

By Christopher M. Matthews | March 16th, 2011

The civil employment suit against the company appears to have led to a criminal investigation by the Justice Department and SEC into potential FCPA violations.

By David Stout | March 15th, 2011

Press reports about the United Kingdom’s Bribery Act have been alarmist, a British official says.

By Christopher M. Matthews | March 7th, 2011

The drug maker has also fallen under the gaze of a separate, industry-wide probe into potential FCPA violations in the pharmaceutical industry currently being conducted by the SEC and the Justice Department.

By David Stout | March 3rd, 2011

What will it mean for multinational companies who do business in China? It’s too soon to say.

By David Stout | March 3rd, 2011

The case of U.S. v. Carson is narrowed a little, but the question remains: “Who is an ‘official’?”




BEST FCPA LAWYERS PRACTICE GROUP OF THE YEAR. Main Justice held an awards luncheon in Washington, D.C., to honor top firms in the Foreign Corrupt Practices Act arena. This video shows announcement of the finalists and winner in the Practice Group of the Year category.

Mary B. Jacoby

Mary Jacoby is the founder of Main Justice and Editor-in-Chief of Just Anti-Corruption.

more
Ernst & Young's FIDS Practices

Dealing with complex issues of fraud, regulatory compliance and business disputes can detract from efforts to achi...more